FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment By Annika Kim Constantino,CNBC • Published January 21, 2025 • Updated on January 21, 2025 at 11:04 am BOOKMARKER ...

Major depressive disorder affects an estimated 8.3% of the adult population. And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug ...